Abond CRO

Abond CRO was a U.S.-based full-service contract research organization serving pharmaceutical, biotechnology, and medical device clients. The company provided outsourced clinical development services including consulting, clinical monitoring, clinical operations, data management, biostatistics, statistical analysis, and medical writing rather than developing its own therapeutic pipeline. Abond appears to have operated primarily as a service provider supporting sponsor-led clinical programs across multiple therapeutic areas. The company ceased operations in December 2023, and in February 2024 Bioforum announced an exclusive deal to acquire Abond's business assets and provide continuity services to Abond's customers.